litlas
Log inCreate account

James M. Boyett

Active 1979–2021

93
Papers
21,249
Citations
82
h-index
93
i10-index

Citations

Citations per year for James M. Boyett1930: 1 citations1984: 1 citations1985: 4 citations1986: 6 citations1987: 5 citations1988: 2 citations1989: 7 citations1990: 15 citations1991: 7 citations1992: 7 citations1993: 12 citations1994: 8 citations1995: 14 citations1996: 24 citations1997: 40 citations1998: 85 citations1999: 153 citations2000: 147 citations2001: 116 citations2002: 163 citations2003: 192 citations2004: 173 citations2005: 172 citations2006: 165 citations2007: 164 citations2008: 189 citations2009: 239 citations2010: 164 citations2011: 191 citations2012: 191 citations2013: 140 citations2014: 140 citations2015: 163 citations2016: 139 citations2017: 121 citations2018: 107 citations2019: 418 citations2020: 437 citations2021: 338 citations2022: 259 citations2023: 140 citations2024: 226 citations2025: 92 citations2026: 1 citations1931–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,153 citing papers, 33.9% of this breakdownGermany: 458 citing papers, 7.2% of this breakdownUnited Kingdom: 453 citing papers, 7.1% of this breakdownCanada: 340 citing papers, 5.4% of this breakdownFrance: 279 citing papers, 4.4% of this breakdownItaly: 277 citing papers, 4.4% of this breakdownNetherlands: 263 citing papers, 4.1% of this breakdownChina: 242 citing papers, 3.8% of this breakdownAustralia: 166 citing papers, 2.6% of this breakdownSwitzerland: 157 citing papers, 2.5% of this breakdownJapan: 117 citing papers, 1.8% of this breakdownAustria: 110 citing papers, 1.7% of this breakdown
0%33.9%Other 21.1%

Institutions

Fields

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Neuroscience1.6%
  • Computer Science1.2%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Immunology and Microbiology0.7%
  • Other2.1%

Topics

  • Glioma Diagnosis and Treatment12.9%
  • Acute Lymphoblastic Leukemia research8.7%
  • Childhood Cancer Survivors' Quality of Life5.9%
  • Neuroblastoma Research and Treatments4.1%
  • Acute Myeloid Leukemia Research3.5%
  • Brain Metastases and Treatment3.4%
  • Other61.5%

Coauthors

All papers

Open in search
  1. Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

    Authors: Ching-Hon Pui, Dario Campana, Deqing Pei, W. Paul Bowman, John T. Sandlund, Sue C. Kaste, Raul C. Ribeiro, Jeffrey E. Rubnitz, Susana C. Raimondi, Mihaela Onciu, Elaine Coustan‐Smith, Larry E. Kun, Sima Jeha, Cheng Cheng, Scott C. Howard, Vickey Simmons, Amy Bayles, Monika L. Metzger, James M. Boyett, Wing Leung, Rupert Handgretinger, James R. Downing, William E. Evans, Mary V. Relling - New England Journal of Medicine 2009 cited by 1,220

  2. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

    Authors: Giles Robinson, Brent A. Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J. Packer, Stewart Goldman, Michael D. Prados, Annick Desjardins, Murali Chintagumpala, Naoko Takebe, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar‐Thomas, Clinton F. Stewart, Maryam Fouladi, James M. Boyett, Richard J. Gilbertson, Tom Curran, David W. Ellison, Amar Gajjar - Journal of Clinical Oncology 2015 cited by 460

  3. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

    Authors: Anuradha Banerjee, Regina I. Jakacki, Arzu Onar‐Thomas, Shengjie Wu, Theodore Nicolaides, Tina Young Poussaint, Jason Fangusaro, Joanna J. Phillips, Arie Perry, David C. Turner, Michael D. Prados, Roger J. Packer, Ibrahim Qaddoumi, Sridharan Gururangan, Ian F. Pollack, Stewart Goldman, L. Austin Doyle, Clinton F. Stewart, James M. Boyett, Larry E. Kun, Maryam Fouladi - Neuro-Oncology 2017 cited by 320

  4. A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study

    Authors: Ralph Salloum, Trent R. Hummel, Shiva Senthil Kumar, Kathleen Dorris, Shaoyu Li, Tong Lin, Vinay M. Daryani, Clinton F. Stewart, Lili Miles, Tina Young Poussaint, Charles B. Stevenson, Stewart Goldman, Girish Dhall, Roger Packer, Paul G. Fisher, Ian F. Pollack, Maryam Fouladi, James M. Boyett, Rachid Drissi - Journal of Neuro-Oncology 2016 cited by 104

  5. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

    Authors: Amar Gajjar, Murali Chintagumpala, David M. Ashley, Stewart J. Kellie, Larry E. Kun, Thomas E. Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J. Krasin, Maryam Fouladi, Alberto Broniscer, Robert A. Krance, Gregory A. Hale, Clinton F. Stewart, Robert Dauser, Robert A. Sanford, Christine Fuller, Ching C. Lau, James M. Boyett, Dana Wallace, Richard J. Gilbertson - The Lancet Oncology 2006 cited by 949

  6. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

    Authors: David W. Ellison, Mehmet Koçak, Dominique Figarella‐Branger, Felice Giangaspero, Godfraind Catherine, Torsten Pietsch, Didier Frappaz, Maura Massimino, Jacques Grill, James M. Boyett, Richard G. Grundy - Journal of Negative Results in BioMedicine 2011 cited by 311

  7. Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study

    Authors: Rishi Lulla, Stewart Goldman, Tohru Yamada, Craig W. Beattie, Linda R. Bressler, Michael Pacini, Ian F. Pollack, Paul G. Fisher, Roger J. Packer, Ira J. Dunkel, Girish Dhall, Shengjie Wu, Arzu Onar, James M. Boyett, Maryam Fouladi - Neuro-Oncology 2016 cited by 140

  8. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

    Authors: R. J. Packer, Joann L. Ater, Jeffrey C. Allen, Peter C. Phillips∥, Russ Geyer, H. Stacy Nicholson, Regina Jakacki, Elizabeth Kurczynski, Michael N. Needle, Jonathan L. Finlay, Gregory H. Reaman, James M. Boyett - Journal of neurosurgery 1997 cited by 639

  9. A statistical framework to evaluate virtual screening

    Authors: Wei Zhao, Kirk E. Hevener, Stephen W. White, Richard E. Lee, James M. Boyett - BMC Bioinformatics, BMC Bioinform. 2009 cited by 106

  10. Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia

    Authors: William E. Evans, Mary V. Relling, John H. Rodman, William R. Crom, James M. Boyett, Ching‐Hon Pui - New England Journal of Medicine 1998 cited by 500

  11. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

    Authors: Elaine Coustan‐Smith, José Sancho, Michael L. Hancock, James M. Boyett, Frederick G. Behm, Susana C. Raimondi, John T. Sandlund, Gaston K. Rivera, Jeffrey E. Rubnitz, Raul C. Ribeiro, Ching‐Hon Pui, Dario Campana - Blood 2000 cited by 473

  12. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

    Authors: Ching‐Hon Pui, Paul S. Gaynon, James M. Boyett, Judith M. Chessells, André Baruchel, Willem A. Kamps, Lewis B. Silverman, Andrea Biondi, D. Harms, E Vilmer, Martin Schrappe, Bruce M. Camitta - The Lancet 2002 cited by 397

  13. Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study

    Authors: Paul M. Zeltzer, James M. Boyett, Jonathan L. Finlay, A. L. Albright, Lucy B. Rorke, Jerrold M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens, Philip Stanley, Hao Li, Jeffrey H. Wisoff, J. Russell Geyer, Patsy McGuire-Cullen, James A. Stehbens, Susan B. Shurin, Roger J. Packer - Journal of Clinical Oncology 1999 cited by 756

  14. Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group

    Authors: J. Russell Geyer, Richard Sposto, Mark T. Jennings, James M. Boyett, Richard A. Axtell, David Breiger, Emmett Broxson, Bernadine R. Donahue, Jonathan L. Finlay, Joel W. Goldwein, Linda Heier, Dennis L. Johnson, Claire Mazewski, Douglas C. Miller, Roger J. Packer, Diane Puccetti, Jerilynn Radcliffe, May Lin Tao, Tania Shiminski‐Maher - Journal of Clinical Oncology 2005 cited by 428

  15. Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma

    Authors: Raymond K. Mulhern, Shawna L. Palmer, Thomas E. Merchant, Dana Wallace, Mehmet Koçak, Pim Brouwers, Kevin R. Krull, Murali Chintagumpala, Robyn Stargatt, David M. Ashley, Vida L. Tyc, Larry E. Kun, James M. Boyett, Amar Gajjar - Journal of Clinical Oncology 2005 cited by 404

  16. Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

    Authors: Maryam Fouladi, Clinton F. Stewart, James M. Olson, Lars M. Wagner, Arzu Onar‐Thomas, Mehmet Koçak, Roger J. Packer, Stewart Goldman, Sridharan Gururangan, Amar Gajjar, Tim Demuth, Larry E. Kun, James M. Boyett, Richard J. Gilbertson - Journal of Clinical Oncology 2011 cited by 167

  17. Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study

    Authors: Roger J. Packer, Joel Goldwein, H. Stacy Nicholson, L. Gilbert Vezina, Jeffrey C. Allen, M. Douglas Ris, Karin M. Muraszko, Lucy B. Rorke, William M. Wara, Bruce H. Cohen, James M. Boyett - Journal of Clinical Oncology 1999 cited by 622

  18. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

    Authors: Jonathan L. Finlay, James M. Boyett, A. J. Yates, Jeffrey H. Wisoff, Jerrold M. Milstein, J. Russell Geyer, Salvatore Bertolone, Patrick McGuire, Joel M. Cherlow, Melvin Tefft - Journal of Clinical Oncology 1995 cited by 367

  19. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study

    Authors: Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, Roger E. McLendon, Arzu Onar‐Thomas, Shengjie Wu, Roger J. Packer, Anu Banerjee, Richard J. Gilbertson, Frederic H. Fahey, Sridhar Vajapeyam, Regina I. Jakacki, Amar Gajjar, Stewart Goldman, Ian F. Pollack, Henry S. Friedman, James M. Boyett, Maryam Fouladi, Larry E. Kun - Neuro-Oncology 2013 cited by 160

  20. Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study

    Authors: Amar Gajjar, Clinton F. Stewart, David W. Ellison, Sue C. Kaste, Larry E. Kun, Roger J. Packer, Stewart Goldman, Murali Chintagumpala, Dana Wallace, Naoko Takebe, James M. Boyett, Richard J. Gilbertson, Tom Curran - Clinical Cancer Research 2013 cited by 215

  21. Comparison of CSF Cytology and Spinal Magnetic Resonance Imaging in the Detection of Leptomeningeal Disease in Pediatric Medulloblastoma or Primitive Neuroectodermal Tumor

    Authors: Maryam Fouladi, Amar Gajjar, James M. Boyett, Andrew W. Walter, Stephen J. Thompson, Thomas E. Merchant, Jesse J. Jenkins, J. William Langston, Aiyi Liu, Larry E. Kun, Richard L. Heideman - Journal of Clinical Oncology 1999 cited by 131

  22. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium

    Authors: Ian F. Pollack, Clinton F. Stewart, Mehmet Koçak, Tina Young Poussaint, Alberto Broniscer, Anuradha Banerjee, James G. Douglas, L. Kun, James M. Boyett, J. Russell Geyer - Neuro-Oncology 2011 cited by 130

  23. Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study

    Authors: Ute Bartels, Arzu Onar‐Thomas, Sunita K. Patel, Dennis Shaw, Jason Fangusaro, Girish Dhall, Mark M. Souweidane, Aashim Bhatia, Leanne Embry, Christine L. Trask, Erin S. Murphy, Shannon M. MacDonald, Shengjie Wu, James M. Boyett, Sarah Leary, Maryam Fouladi, Amar Gajjar, Soumen Khatua - Neuro-Oncology 2021 cited by 72

  24. Magnetic Resonance Scans Should Replace Biopsies for the Diagnosis of Diffuse Brain Stem Gliomas

    Authors: A. L. Albright, Roger J. Packer, Robert A. Zimmerman, Lucy B. Rorke, James M. Boyett, G. Denman Hammond - Neurosurgery 1993 cited by 319